Robert Kraal to Join myTomorrows as COO

USA Profile Username: jon@newsinnovations.com / edit profile Robert Kraal to Join myTomorrows as COO PR Newswire AMSTERDAM, July 5, 2016 AMSTERDAM, July 5, 2016 /PRNewswire/ -- myTomorrows today announced that Robert Kraal (41) has been named Chief Operating Officer, effective immediately. As COO Robert will be responsible for scaling-up the myTomorrows platform that supports doctors and patients facing unmet medical needs with access to development stage drugs. "We are excited to add more tech breadth and depth to our leadership team. Robert brings unique platform experience from an analogous space, payment services. Where privacy, regulation and compliance are critical to serve diligently the needs of our stakeholders. He is uniquely equipped to support our aim to empower all with real-life data to support rational pharmacotherapy." CEO/Founder Ronald Brus "The myTomorrows mission attracted me powerfully. It was a simple case of this has to be done. Patients and doctors need earlier access to drugs and relevant real life data. I'm thrilled to join this international team driven by such a compelling vision." Robert Kraal Having graduated in 1998 with a Master of Science in Geophysics from Utrecht University,  Robert has built his career around driving strategic prioritization and accountability within emerging tech companies.  Prior to this appointment, Robert founded and globally expanded the card acquiring businesses for Adyen and also held the COO position there. Previously Robert was board member for Google Benelux. He was also a member of the initial start-up team of Bibit/WorldPay and worked as operations and partnerships director for Docdata Payments. About myTomorrows  myTomorrows provides access services to patients and physicians in need of diagnostic tests and drugs in development. The myTomorrows internet platform also offers uniform public information about early access programs, clinical trials and diagnostic tests to enhance data-driven decision making and enables rational pharmacotherapy. http://www.mytomorrows.com Contact Erdem Yavuz, +31-88-525-3888, Erdem.Yavuz@mytomorrows.com Follow Us To change the settings for your profile(s) or email delivery, go to https://prnmedia.prnewswire.com/profile/?action=editProfile and select the profile you would like to edit. You can select the industries, subjects, languages, geographical areas, companies, delivery options and delivery frequencies of your choice. In addition to current press releases, you can also find archived news, corporate information, photos, tradeshow news and much more on the PR Newswire for Journalists website: https://prnmedia.prnewswire.com To contact us, email: mediasite@prnewswire.com Please do not reply to this email; this is an automatically generated message. Copyright © PR Newswire Association LLC. All Rights Reserved. A UBM plc company. Our mailing address is: 350 Hudson Street, Suite 300 New York, NY 10014-4504